Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
J Thromb Thrombolysis ; 49(1): 145-148, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31471774

RESUMEN

Pregnancy-associated acute myocardial infarction is a rare condition usually occurring during the third trimester of pregnancy, and associated with three-to-four-fold higher mortality compared with rates among non-pregnant women of the same age. As in non-pregnant women, in cases of ST elevation myocardial infarction, the most effective treatment is primary percutaneous coronary intervention with stent implantation. Unfortunately, management of these patients could be challenging because little is known about the optimal medical strategy; the potential teratogenic effects of the third generation thienopyridines are not fully established too. In fact current guidelines do not provide enough recommendations about tailoring dual antiplatelet therapy prescription according to ischemic profile of the pregnant patients. Moreover, the bleeding risk class of cesarean delivery/hysterectomy is not stated in current consensus documents. We report the second pregnancy-associated acute myocardial infarction case successfully treated with ticagrelor before and after primary percutaneous coronary intervention with drug eluting stent implantation on left coronary artery, but also the first report on use of bridging antiplatelet therapy with tirofiban during temporary withdrawal of ticagrelor because of a C-section.


Asunto(s)
Nacimiento Vivo , Complicaciones Cardiovasculares del Embarazo/tratamiento farmacológico , Infarto del Miocardio con Elevación del ST/tratamiento farmacológico , Ticagrelor/administración & dosificación , Tirofibán/administración & dosificación , Adulto , Cesárea , Femenino , Humanos , Embarazo
2.
Future Cardiol ; 13(6): 533-537, 2017 11.
Artículo en Inglés | MEDLINE | ID: mdl-29034726

RESUMEN

Endocarditis of a prosthetic heart valve is a life-threatening condition that is associated with high morbidity and mortality. Perivalvular extension in infective endocarditis includes complications such as periannular or intramyocardial abscesses, pseudoaneurysms and fistulae. The incidence of perivalvular extension ranges from 10 to 30% in native valve endocarditis and 30 to 55% in prosthetic aortic-valve endocarditis. Herein, we describe a case of a 66-year-old man who presented endocarditis of a prosthetic aortic valve complicated by infective pseudoaneurysm with localization next to the right coronary sinus of Valsalva. Moreover, we underscore the importance of the diagnostic imaging tools options and surgical timing.


Asunto(s)
Aneurisma Falso/cirugía , Insuficiencia de la Válvula Aórtica/cirugía , Seno Coronario/cirugía , Endocarditis Bacteriana/cirugía , Implantación de Prótesis de Válvulas Cardíacas/efectos adversos , Infecciones Relacionadas con Prótesis/cirugía , Anciano , Aneurisma Falso/diagnóstico por imagen , Aneurisma Falso/etiología , Insuficiencia de la Válvula Aórtica/diagnóstico por imagen , Seno Coronario/diagnóstico por imagen , Seno Coronario/fisiopatología , Remoción de Dispositivos , Ecocardiografía/métodos , Ecocardiografía Transesofágica/métodos , Endocarditis Bacteriana/etiología , Endocarditis Bacteriana/fisiopatología , Estudios de Seguimiento , Prótesis Valvulares Cardíacas , Implantación de Prótesis de Válvulas Cardíacas/métodos , Humanos , Masculino , Infecciones Relacionadas con Prótesis/diagnóstico por imagen , Reoperación/métodos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA